8th Jan 2026. 9.04am
Regency View:
Update

Regency View:
Update
The traditionally sleepy festive period has been anything but quiet for our AIM stocks. Trading updates, contract wins, acquisitions and takeover developments dominated newsflow over the holidays, giving investors a useful run of information heading into the first full week of 2026.
Celebrus Technologies steadies ARR despite softer headline numbers
Celebrus Technologies (CLBS) reported half year results that reflected the impact of changes to contract structures and revenue recognition, with total revenue lower year on year. Beneath that, Annual Recurring Revenue rose to $15.6m and gross margins strengthened materially as the mix continued to shift away from lower margin hardware.
Operational progress remained encouraging, with a blend of new customer wins and upsells across existing clients. Product development continues to focus on analytics, identity and AI driven capabilities, supporting the long term software proposition.

From an investor perspective, this was a transitional set of numbers rather than a deterioration in underlying quality. The balance sheet remains strong, dividends were maintained, and ARR momentum continues to build.
What we are watching next: progress in converting late stage pipeline opportunities into signed contracts.
Themes: Half year
Duke Capital shows the strength of its income model
Duke Capital (DUKE) delivered interim results that underlined the resilience of its hybrid capital model. Recurring cash revenue increased to £13.2m while free cash flow held steady at £5.9m, achieved without any investment exits during the period.
Cost discipline was a clear positive, with operating expenses down 21% year on year, supporting cash generation and dividend coverage. Duke also continued to deploy capital into existing partners, including post period investment activity in healthcare assets.

For income focused investors, the message was consistency rather than excitement. Duke continues to do what it says on the tin, providing reliable cash flows through a challenging backdrop.
What we are watching next: consistency of free cash flow generation without reliance on investment exits.
Themes: Half year | Trading update
eEnergy resets timing but upgrades the outlook
eEnergy Group (EAAS) issued a trading update highlighting strong demand and a rapidly expanding pipeline, particularly in solar PV and public sector frameworks. Several large installations were delayed, pushing £3m to £4m of expected FY25 revenue into early FY26.
While frustrating in the short term, this timing shift was accompanied by upgraded FY26 guidance, with revenue now expected to reach £34m and adjusted EBITDA £4.5m. The funding partnership with Redaptive and growing framework participation continue to support scale.
For investors, this was a reminder that timing risk remains part of the model, but the medium term trajectory appears stronger as contract visibility improves.
What we are watching next: pace of installations in H1 2026 as delayed projects move into delivery.
Themes: Trading update
FRP Advisory continues to compound steadily
FRP Advisory (FRP) reported a solid set of half year results, with revenue up 12% and adjusted EBITDA rising to £23.0m. Growth was delivered through a mix of organic progress and selective acquisitions, supported by strong cash collection and a net cash position.
Activity levels remained healthy across restructuring, corporate finance and forensic services, while recent acquisitions broadened the service offering and geographic reach. Interim dividends were increased again, reflecting confidence in cash generation.

This update reinforced FRP’s position as a high quality professional services business capable of performing across cycles, with balance sheet strength providing optionality.
What we are watching next: demand trends following the Autumn Budget and pipeline conversion in H2.
Themes: Half year
HSS name change: ProService completes its transformation
ProService Building Services Marketplace (PRO), formerly HSS Hire, reported interim results alongside confirmation of its transition to a pure play marketplace model. The disposal of the hire business and new commercial agreement with Speedy Hire marked a structural reset.
Short term trading remains challenging, with FY26 expected to be broadly breakeven at the EBITDA level as integration costs flow through. Management remains confident that FY27 will reflect the earnings potential of the asset light model.

This is now a different business altogether, with execution risk but a clearer strategic focus.
What we are watching next: stabilisation of revenues and evidence of margin uplift from the Speedy Hire partnership.
Themes: Half year | Strategic update
hVIVO insiders put money to work
hVIVO (HVO) announced share purchases by both the CEO and CFO during December, with meaningful personal capital committed at current price levels. Insider buying of this scale is rarely accidental and tends to reflect confidence in the outlook.
The business continues to position itself as a global leader in human challenge trials, with demand supported by vaccine, antiviral and respiratory research activity.
While not a trading update in itself, insider alignment matters, particularly in a capital intensive CRO model.

What we are watching next: contract wins and booking momentum into the new financial year.
Themes: Director dealings
Netcall adds scale and momentum
Netcall (NET) had an active festive period, completing the acquisition of Jadu and announcing a £3.0m multi year Liberty Cloud contract with a global financial services group. The acquisition broadens Netcall’s addressable market and strengthens its position in UK local government.
The Jadu deal adds complementary digital experience and AI capabilities to the Liberty platform, while also creating clear cross-sell opportunities across Netcall’s existing customer base. With Jadu bringing a largely cloud-based recurring revenue profile, the transaction also aligns well with Netcall’s strategy of improving revenue visibility and quality.

Alongside the acquisition, the new multi-year Liberty Cloud contract underlines the platform’s ability to scale into complex, enterprise-wide deployments. The expansion of an existing relationship into a core operational use case reinforces the Group’s land-and-expand model and adds further confidence around medium-term recurring revenue growth.
What we are watching next: integration of Jadu and expansion of ACV across enterprise customers.
Themes: Acquisition | Contract win
Nexteq flags near term headwinds but keeps long term plan intact
Nexteq (NXQ) updated the market on FY25 trading, confirming results in line with expectations but warning of a softer FY26 due to customer consolidation within its gaming division. Revenue is now expected to be no less than $85m next year.
Importantly, management reiterated confidence in the longer term three year plan, highlighting diversification, product development and expansion into new markets as mitigating factors.

This was a reminder that earnings can be lumpy in specialist industrial technology, even as strategic progress continues behind the scenes.
What we are watching next: evidence that diversification offsets gaming related volume declines.
Themes: Trading update
Synectics delivers a strong finish to FY25
Synectics (SNX) reported a robust full year trading update, with revenue rising to around £68m and adjusted EBITDA increasing to £8.5m. Cash balances reached a record £14.1m, supporting an increased dividend.
While results benefited from a large one off gaming contract, management continues to shift the business toward a more scalable, product led model with broader sector exposure.

From an investor standpoint, the balance sheet strength and strategic transition remain key attractions as the company moves into FY26.
What we are watching next: order intake quality as the business laps a large non recurring contract.
Themes: Full year | Trading update
1Spatial moves firmly into takeover territory
1Spatial (SPA) announced agreement in principle on a possible cash offer at 73p per share from VertiGIS, backed by Battery Ventures. The board has indicated its intention to recommend the offer should it proceed.
The proposal values the business at approximately £87m and has the support of major shareholders, offering liquidity at a meaningful premium to recent trading.

For investors, this shifts the focus from execution to deal certainty and timing.
What we are watching next: progression to a firm offer ahead of the Rule 2.6 deadline.
Themes: Takeover
Inspecs deal momentum accelerates
Inspecs (SPEC) remains in a live takeover process following the recommended 84p per share cash offer announced in December. While the shares initially reacted positively, subsequent volatility reflects the dynamics of an active offer period rather than any change to the agreed terms.
The disclosure that Safilo has acquired a 25 percent stake has added complexity, but it does not alter the board’s unanimous recommendation or the structure of the transaction. With Takeover Code restrictions now in place, near-term price movements are likely being driven by positioning and arbitrage rather than fundamentals.

WThe underlying investment case is now largely binary. Shareholders are being offered a defined cash exit at a substantial premium, bringing clarity after a prolonged period of earnings volatility and operational challenges. Attention therefore shifts away from trading performance and toward deal execution.
What we are watching next: progress through the scheme process and key timetable updates.
Themes: Takeover
Tristel starts the year strongly
Tristel (TSTL) delivered a confident AGM update during December, reporting a strong start to the new financial year with trading in line with expectations and revenue growth of at least 10 percent targeted for the year. Momentum continues to be driven by robust demand across hospital customers, with seasonal strength expected to support a more heavily weighted second half.
The update highlighted particularly encouraging progress in the United States, where sales growth has accelerated sharply. Early traction from Tristel ULT and the successful launch of Tristel OPH have driven a step-change in US revenues, supported by inclusion in national clinical guidelines and expanding adoption across healthcare settings.

Across Europe, growth remains steady and strategically important, reinforcing the region’s role as a core pillar of the Group’s international expansion. With a growing product portfolio and improving geographic mix, the business enters the remainder of the year with clear operational momentum.
What we are watching next: continued US scaling and margin progression.
Themes: Trading update
Disclaimer:
All content is provided for general information only and should not be construed as any form of advice or personal recommendation. The provision of this content is not regulated by the Financial Conduct Authority.











